Cell Biology and Toxicology

, Volume 26, Issue 6, pp 541–551 | Cite as

Tert-butylhydroquinone induces mitochondrial oxidative stress causing Nrf2 activation

Article

Abstract

Tert-butylhydroquinone (tBHQ), the major metabolite of butylated hydroxyanisole, induces an antioxidant response through the redox-sensitive transcription factor, nuclear factor-E2-related factor-2 (Nrf2). However, the mechanism by which tBHQ induces Nrf2 activity is not entirely understood. Here, we show that tBHQ preferentially alters the redox status in the mitochondrial compartment in HeLa cells. HeLa cells treated with tBHQ showed a preferential oxidation of mitochondrial thioredoxin-2 (Trx2), while cellular glutathione and cytosolic thioredoxin-1 were not affected. Preferential mitochondrial oxidation by tBHQ was supported by detection of reactive oxygen species (ROS) specific to this compartment. To determine the role of Trx2 in regulating downstream effects of tBHQ, HeLa cells were transiently transfected with an empty, Trx2, or C93S (Cys93Ser) Trx2 dominant-negative mutant expression vector. Overexpression of Trx2 decreased basal mitochondrial ROS production, whereas expression of C93S Trx2 enhanced it. In addition, under untreated conditions, expression of C93S Trx2 led to an increase in the basal activities of Nrf2. With tBHQ treatments, Trx2 overexpression suppressed Nrf2 accumulation and activity, whereas expression of C93S Trx2 had no effect on the degree of inducibility or Nrf2 accumulation but did increase the overall activity of Nrf2. Quantitative polymerase chain reaction analysis of Nrf2-regulated gene expression corroborate Trx2 control of tBHQ-mediated Nrf2 activation. These data show a compartment-specific effect where tBHQ-induced Nrf2 signaling is mediated by Trx2 and suggest that antioxidant status in various compartments would provide different levels of control of redox signaling.

Keywords

Mitochondria Nrf2 Oxidative stress Tert-butylhyrdroquinone Thioredoxin 

References

  1. Altmann HJ, Grunow W, Wester PW, Mohr U. Induction of forestomach lesions by butylhydroxyanisole and structurally related substances. Arch Toxicol Suppl. 1985;8:114–6.PubMedGoogle Scholar
  2. Chen Y, Cai J, Murphy TJ, Jones DP. Overexpressed human mitochondrial thioredoxin confers resistance to oxidant-induced apoptosis in human osteosarcoma cells. J Biol Chem. 2002;277:33242–8.CrossRefPubMedGoogle Scholar
  3. Copple IM, Goldring CE, Kitteringham NR, Park BK. The Nrf2-Keap1 defence pathway: role in protection against drug-induced toxicity. Toxicology. 2008;246:24–33.PubMedGoogle Scholar
  4. Erickson AM, Nevarea Z, Gipp JJ, Mulcahy RT. Identification of a variant antioxidant response element in the promoter of the human glutamate-cysteine ligase modifier subunit gene. Revision of the ARE consensus sequence. J Biol Chem. 2002;277:30730–7.CrossRefPubMedGoogle Scholar
  5. Fahey JW, Haristoy X, Dolan PM, Kensler TW, Scholtus I, Stephenson KK, et al. Sulforaphane inhibits extracellular, intracellular, and antibiotic-resistant strains of Helicobacter pylori and prevents benzo[a]pyrene-induced stomach tumors. Proc Natl Acad Sci U S A. 2002;99:7610–5.CrossRefPubMedGoogle Scholar
  6. Fukushima S, Shibata MA, Hirose M, Kato T, Tatematsu M, Ito N. Organ-specific modification of tumor development by low-dose combinations of agents in a rat wide-spectrum carcinogenesis model. Jpn J Cancer Res. 1991;82:784–92.PubMedGoogle Scholar
  7. Gharavi N, Haggarty S, El-Kadi AO. Chemoprotective and carcinogenic effects of tert-butylhydroquinone and its metabolites. Curr Drug Metab. 2007;8:1–7.CrossRefPubMedGoogle Scholar
  8. Halvey PJ, Watson WH, Hansen JM, Go YM, Samali A, Jones DP. Compartmental oxidation of thiol-disulphide redox couples during epidermal growth factor signalling. Biochem J. 2005;386:215–9.CrossRefPubMedGoogle Scholar
  9. Halvey PJ, Hansen JM, Johnson JM, Go YM, Samali A, Jones DP. Selective oxidative stress in cell nuclei by nuclear-targeted D-amino acid oxidase. Antioxid Redox Signal. 2007;9:807–16.CrossRefPubMedGoogle Scholar
  10. Hansen JM, Watson WH, Jones DP. Compartmentation of Nrf-2 redox control: regulation of cytoplasmic activation by glutathione and DNA binding by thioredoxin-1. Toxicol Sci. 2004;82:308–17.CrossRefPubMedGoogle Scholar
  11. Hansen JM, Go YM, Jones DP. Nuclear and mitochondrial compartmentation of oxidative stress and redox signaling. Annu Rev Pharmacol Toxicol. 2006a;46:215–34.CrossRefPubMedGoogle Scholar
  12. Hansen JM, Zhang H, Jones DP. Differential oxidation of thioredoxin-1, thioredoxin-2, and glutathione by metal ions. Free Radic Biol Med. 2006b;40:138–45.CrossRefPubMedGoogle Scholar
  13. Hansen JM, Zhang H, Jones DP. Mitochondrial thioredoxin-2 has a key role in determining tumor necrosis factor-alpha-induced reactive oxygen species generation, NF-kappaB activation, and apoptosis. Toxicol Sci. 2006c;91:643–50.CrossRefPubMedGoogle Scholar
  14. Hansen JM, Moriarty-Craige S, Jones DP. Nuclear and cytoplasmic peroxiredoxin-1 differentially regulate NF-kappaB activities. Free Radic Biol Med. 2007;43:282–8.CrossRefPubMedGoogle Scholar
  15. Hara H, Ohta M, Ohta K, Kuno S, Adachi T. Increase of antioxidative potential by tert-butylhydroquinone protects against cell death associated with 6-hydroxydopamine-induced oxidative stress in neuroblastoma SH-SY5Y cells. Brain Res Mol Brain Res. 2003;119:125–31.CrossRefPubMedGoogle Scholar
  16. Hasegawa R, Tiwawech D, Hirose M, Takaba K, Hoshiya T, Shirai T, et al. Suppression of diethylnitrosamine-initiated preneoplastic foci development in the rat liver by combined administration of four antioxidants at low doses. Jpn J Cancer Res. 1992;83:431–7.PubMedGoogle Scholar
  17. Hayes JD, McMahon M. NRF2 and KEAP1 mutations: permanent activation of an adaptive response in cancer. Trends Biochem Sci. 2009;34:176–88.CrossRefPubMedGoogle Scholar
  18. Hirose M, Yada H, Hakoi K, Takahashi S, Ito N. Modification of carcinogenesis by alpha-tocopherol, t-butylhydroquinone, propyl gallate and butylated hydroxytoluene in a rat multi-organ carcinogenesis model. Carcinogenesis. 1993;14:2359–64.CrossRefPubMedGoogle Scholar
  19. Hirota K, Murata M, Sachi Y, Nakamura H, Takeuchi J, Mori K, et al. Distinct roles of thioredoxin in the cytoplasm and in the nucleus. A two-step mechanism of redox regulation of transcription factor NF-kappaB. J Biol Chem. 1999;274:27891–7.CrossRefPubMedGoogle Scholar
  20. Itoh K, Wakabayashi N, Katoh Y, Ishii T, Igarashi K, Engel JD, et al. Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. Genes Dev. 1999;13:76–86.CrossRefPubMedGoogle Scholar
  21. Jones DP. Redox potential of GSH/GSSG couple: assay and biological significance. Methods Enzymol. 2002;348:93–112.CrossRefPubMedGoogle Scholar
  22. Jones DP. Redefining oxidative stress. Antioxid Redox Signal. 2006;8:1865–79.CrossRefPubMedGoogle Scholar
  23. Kensler TW, Wakabayashi N, Biswal S. Cell survival responses to environmental stresses via the Keap1-Nrf2-ARE pathway. Annu Rev Pharmacol Toxicol. 2007;47:89–116.CrossRefPubMedGoogle Scholar
  24. Kobayashi M, Li L, Iwamoto N, Nakajima-Takagi Y, Kaneko H, Nakayama Y, et al. The antioxidant defense system Keap1-Nrf2 comprises a multiple sensing mechanism for responding to a wide range of chemical compounds. Mol Cell Biol. 2009;29:493–502.CrossRefPubMedGoogle Scholar
  25. Kraft AD, Johnson DA, Johnson JA. Nuclear factor E2-related factor 2-dependent antioxidant response element activation by tert-butylhydroquinone and sulforaphane occurring preferentially in astrocytes conditions neurons against oxidative insult. J Neurosci. 2004;24:1101–12.CrossRefPubMedGoogle Scholar
  26. Li J, Lee JM, Johnson JA. Microarray analysis reveals an antioxidant responsive element-driven gene set involved in conferring protection from an oxidative stress-induced apoptosis in IMR-32 cells. J Biol Chem. 2002a;277:388–94.CrossRefPubMedGoogle Scholar
  27. Li Y, Seacat A, Kuppusamy P, Zweier JL, Yager JD, Trush MA. Copper redox-dependent activation of 2-tert-butyl(1, 4)hydroquinone: formation of reactive oxygen species and induction of oxidative DNA damage in isolated DNA and cultured rat hepatocytes. Mutat Res. 2002b;518:123–33.PubMedGoogle Scholar
  28. Li HY, Zhong YF, Wu SY, Shi N. NF-E2 related factor 2 activation and heme oxygenase-1 induction by tert-butylhydroquinone protect against deltamethrin-mediated oxidative stress in PC12 cells. Chem Res Toxicol. 2007;20:1242–51.CrossRefPubMedGoogle Scholar
  29. Liu RM, Vasiliou V, Zhu H, Duh JL, Tabor MW, Puga A, et al. Regulation of [Ah] gene battery enzymes and glutathione levels by 5, 10-dihydroindeno[1, 2-b]indole in mouse hepatoma cell lines. Carcinogenesis. 1994;15:2347–52.CrossRefPubMedGoogle Scholar
  30. McMahon M, Itoh K, Yamamoto M, Hayes JD. Keap1-dependent proteasomal degradation of transcription factor Nrf2 contributes to the negative regulation of antioxidant response element-driven gene expression. J Biol Chem. 2003;278:21592–600.CrossRefPubMedGoogle Scholar
  31. Miseta A, Csutora P. Relationship between the occurrence of cysteine in proteins and the complexity of organisms. Mol Biol Evol. 2000;17:1232–9.PubMedGoogle Scholar
  32. Nakagawa Y. Effects of dicoumarol on cytotoxicity caused by tert-butylhydroquinone in isolated rat hepatocytes. Toxicol Lett. 1996;84:63–8.CrossRefPubMedGoogle Scholar
  33. Nakagawa Y, Nakajima K, Moore G, Moldeus P. On the mechanisms of 3-tert-butyl-4-hydroxyanisole-and its metabolites-induced cytotoxicities in isolated rat hepatocytes. Eur J Pharmacol. 1994;270:341–8.PubMedGoogle Scholar
  34. Nakamura Y, Kumagai T, Yoshida C, Naito Y, Miyamoto M, Ohigashi H, et al. Pivotal role of electrophilicity in glutathione S-transferase induction by tert-butylhydroquinone. Biochemistry. 2003;42:4300–9.CrossRefPubMedGoogle Scholar
  35. Nakaso K, Yano H, Fukuhara Y, Takeshima T, Wada-Isoe K, Nakashima K. PI3K is a key molecule in the Nrf2-mediated regulation of antioxidative proteins by hemin in human neuroblastoma cells. FEBS Lett. 2003;546:181–4.CrossRefPubMedGoogle Scholar
  36. Okubo T, Yokoyama Y, Kano K, Kano I. Cell death induced by the phenolic antioxidant tert-butylhydroquinone and its metabolite tert-butylquinone in human monocytic leukemia U937 cells. Food Chem Toxicol. 2003;41:679–88.CrossRefPubMedGoogle Scholar
  37. Peters MM, Rivera MI, Jones TW, Monks TJ, Lau SS. Glutathione conjugates of tert-butyl-hydroquinone, a metabolite of the urinary tract tumor promoter 3-tert-butyl-hydroxyanisole, are toxic to kidney and bladder. Cancer Res. 1996;56:1006–11.PubMedGoogle Scholar
  38. Petzer JP, Navamal M, Johnson JK, Kwak MK, Kensler TW, Fishbein JC. Phase 2 enzyme induction by the major metabolite of oltipraz. Chem Res Toxicol. 2003;16:1463–9.CrossRefPubMedGoogle Scholar
  39. Pinkus R, Weiner LM, Daniel V. Role of oxidants and antioxidants in the induction of AP-1, NF-kappaB, and glutathione S-transferase gene expression. J Biol Chem. 1996;271:13422–9.CrossRefPubMedGoogle Scholar
  40. Rhee SG, Kang SW, Chang TS, Jeong W, Kim K. Peroxiredoxin, a novel family of peroxidases. IUBMB Life. 2001;52:35–41.CrossRefPubMedGoogle Scholar
  41. Rhee SG, Chae HZ, Kim K. Peroxiredoxins: a historical overview and speculative preview of novel mechanisms and emerging concepts in cell signaling. Free Radic Biol Med. 2005;38:1543–52.CrossRefPubMedGoogle Scholar
  42. Rushmore TH, Morton MR, Pickett CB. The antioxidant responsive element. Activation by oxidative stress and identification of the DNA consensus sequence required for functional activity. J Biol Chem. 1991;266:11632–9.PubMedGoogle Scholar
  43. Schilderman PA, van Maanen JM, Smeets EJ, ten Hoor F, Kleinjans JC. Oxygen radical formation during prostaglandin H synthase-mediated biotransformation of butylated hydroxyanisole. Carcinogenesis. 1993;14:347–53.CrossRefPubMedGoogle Scholar
  44. Solis WA, Dalton TP, Dieter MZ, Freshwater S, Harrer JM, He L, et al. Glutamate-cysteine ligase modifier subunit: mouse Gclm gene structure and regulation by agents that cause oxidative stress. Biochem Pharmacol. 2002;63:1739–54.CrossRefPubMedGoogle Scholar
  45. Wang H, Joseph JA. Quantifying cellular oxidative stress by dichlorofluorescein assay using microplate reader. Free Radic Biol Med. 1999;27:612–6.CrossRefPubMedGoogle Scholar
  46. Watson WH, Pohl J, Montfort WR, Stuchlik O, Reed MS, Powis G, et al. Redox potential of human thioredoxin 1 and identification of a second dithiol/disulfide motif. J Biol Chem. 2003;278:33408–15.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media B.V. 2010

Authors and Affiliations

  1. 1.Division of Pulmonary, Allergy and Immunology, Cystic Fibrosis and Sleep, Department of Pediatrics, Emory School of MedicineEmory UniversityAtlantaUSA

Personalised recommendations